In the present study, we investigated whether LpPLA2 activity on foetal lipoproteins is altered by maternal GDM and/or obesity (a major risk factor for GDM), thereby contributing to changes in lipoprotein functionality. This evidence concerns the gene PLA2G7 and obesity due to melanocortin 4 receptor deficiency.